PDF-ADHERENCE TO AND COMPLIANCE

Author : genevieve | Published Date : 2022-08-16

WITH ARMS CONTROL NONPROLIFERATION AND D ISARMAMENT AGREEMENTS AND COMMITMENTS April 202 2 Prepared by the US Department of State ii TABLE OF CONTENTS INTRODUCTION 1

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "ADHERENCE TO AND COMPLIANCE" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

ADHERENCE TO AND COMPLIANCE: Transcript

WITH ARMS CONTROL NONPROLIFERATION AND D ISARMAMENT AGREEMENTS AND COMMITMENTS April 202 2 Prepared by the US Department of State ii TABLE OF CONTENTS INTRODUCTION 1 PURPOSE 1 SCOPE O. Doyle M. Cummings, PharmD, FCP, FCCP. Professor of Family Medicine and Public Health. East Carolina University, Brody School of Medicine. Greenville, North Carolina. . [Residency educators may . adapt and use . Meck Chongo, . Virginia . Russell, . Josée. Lavoie, Ross Hoffman, . Mamdouh. . Shubair. University of Northern British Columbia. Agenda. . Background. Objectives . Participants & Research Environment. Bernard Vrijens, PhD. Chief Science Officer, MWV Healthcare. Associate Professor of Biostatistics . University of Liège, Belgium. Adherence is key to therapeutic success. 2. Effective. Disease. Management. Reasons why patients do not adhere. Measuring adherence and non adherence. Improving adherence. Reasons for non-adherence: cognitive rational non-adherence. Adherence is all about being conscientious in following medical advice. . Ronni. AW Wetmore, RN, MS. Coordinator, Stanford Adult Cystic Fibrosis Center. Speaker Bureau: . Chiesi. Pharmaceuticals. Nurse Advisory Board: Genentech Pharmaceutical Company. Nurse Advisory Board: Gilead Pharmaceutical. Jessica Haberer, MD, MS. July . 24, . 2017. Conflicts of Interest. I have no conflicts to declare. Grant funding: US National Institutes of Health, Bill and Melinda Gates Foundation, USAID. Consultation: US National Institutes of Health, World Health Organization, Merck. Angelica Lindsey-Ali & Calicia White. Ebony House Inc.. Objectives. By the end of this section, participants should be able to. : . Understand the difference between cultural humility and cultural competence. Reasons why patients do not adhere. Measuring adherence and non adherence. Improving adherence. Adherence is all about being conscientious in following medical advice. . This . section looks specifically at following recommendations for taking . Ronni. AW Wetmore, RN, MS. Coordinator, Stanford Adult Cystic Fibrosis Center. Speaker Bureau: . Chiesi. Pharmaceuticals. Nurse Advisory Board: Genentech Pharmaceutical Company. Nurse Advisory Board: Gilead Pharmaceutical. Janice M. . Bissonnette. Journal of Advanced Nursing. 63(6), 634-643. Nursing 8440. October 15, 2012. Jennifer Bauman, RN, BA, PCCN. Background. 2003 WHO initiative to improve rates of adherence to therapies for chronic conditions . Patients do . not. take their medicine . as prescribed. about . half. the time. . 2. Why is it important to assess adherence?. =. 3. 4. Eight. . steps to . improve medication adherence. in . your. Conversation & Controversy in Immunosuppression. ENV-17-038.0. Definition and components of medication adherence. Trends and rates of adherence among different subgroups. Impact of adherence on kidney transplant recipients. 1 City in Addis Ababa A Proposal on the CHBC Project Lisan Atnafe: CHBC Project Officer Anley Haile : MNCH project advisor February 2013 2 Acronyms AIDS Acquired Immunodeficiency Syndrome AMREF Afr AbstractBackground: The global burden is estimated to be 1% affecting over 65 million people it has profound physical, psychological and social impacts with a greater impact on a person’s quality

Download Document

Here is the link to download the presentation.
"ADHERENCE TO AND COMPLIANCE"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.